RecruitingPhase 1ACTRN12606000407594

Feasibility Clinical Study of the Ovalis, Inc. Patent Foramen Ovale (PFO) Closure System in Patients with Cryptogenic Neurologic Events, Migraines, and Decompression Illness

A feasibility clinical study of the Ovalis,Inc. Patent Foramen Ovale (PFO) Closure System in patients with cryptogenic neurologic events, migraines, and decompression illness due to patent foramen to assess incidence of adverse effects from this procedure.


Sponsor

Robust Industries

Enrollment

30 participants

Start Date

Jun 4, 2007

Study Type

Interventional

Conditions

Summary

The purpose of this study is to evaluate the safety and feasibility ofa new Patent Foramen Ovale (PFO) closure device. The foramen ovale is a hole in the wall that divides the two sides of the heart. It’s present in the heart of a developing fetus, but normally it closes up soon after the baby is born. If it doesn’t close up, it’s known as a patent foramen ovale (PFO).


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 65 Yearss

Plain Language Summary

Simplified for easier understanding

This study is testing a new device designed to close a small hole in the heart called a Patent Foramen Ovale (PFO). A PFO is an opening between the upper chambers of the heart that normally closes at birth. When it stays open, blood clots can potentially pass through it and cause a stroke or other problems. The device is inserted through a vein (not open heart surgery) and is designed to plug the hole permanently. The study is evaluating whether this new closure device is safe and can be used effectively. You may be eligible if: - You are between 18 and 65 years old - You have been confirmed to have a PFO with blood flow passing through it from right to left - You have a history of: stroke or mini-stroke (TIA), blood clots passing from right to left heart, low blood oxygen in the right side of the heart, severe decompression illness (from scuba diving or flying), OR severe migraines not responding to medication You may NOT be eligible if: - You have a mass (clot or tumour) inside a blood vessel or your heart - You have a large hole (atrial septal defect) in your heart - You have a bleeding disorder, severe kidney problems, or unstable blood pressure - You have recently had a heart attack, stroke, or mini-stroke - You have had a head injury or seizures Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The Patent Foramen Ovale(PFO) Closure System is a delivery system and permanent implant for percutaneous closure of the patent foramen ovale. Percutaneous closure of a patent foramen ovale is a way of

The Patent Foramen Ovale(PFO) Closure System is a delivery system and permanent implant for percutaneous closure of the patent foramen ovale. Percutaneous closure of a patent foramen ovale is a way of closing the foramen ovale without opening up the chest. A small cut or incision is made in the groin area. A narrow tube called a catheter is passed into the incision and into a blood vessel. The catheter contains a special closing device, and this is passed up though the blood vessels to the heart. The closing device is moved into position at the foramen ovale and then released so that it keeps the two tissue flaps together. X-rays and ultrasound will be used during the procedure to evaluate the device placement. The patient will be monitored at one month, six months and twelve months to assess the patients response to the implant.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000407594